BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 9169956)

  • 1. Choosing drug of choice from restrictive formulary.
    Bender KJ
    J Clin Psychopharmacol; 1997 Jun; 17(3):145-8. PubMed ID: 9169956
    [No Abstract]   [Full Text] [Related]  

  • 2. Managing psychotropic drug costs: will formularies work?
    Huskamp HA
    Health Aff (Millwood); 2003; 22(5):84-96. PubMed ID: 14515884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coverage and prior authorization of psychotropic drugs under Medicare Part D.
    Huskamp HA; Stevenson DG; Donohue JM; Newhouse JP; Keating NL
    Psychiatr Serv; 2007 Mar; 58(3):308-10. PubMed ID: 17325102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic grand rounds: the mismanagement of medication management.
    Fleishman M
    Psychiatr Serv; 2000 Apr; 51(4):457-9. PubMed ID: 10737818
    [No Abstract]   [Full Text] [Related]  

  • 5. Implications of Part D for mentally ill dual eligibles: a challenge for Medicare.
    Morden NE; Garrison LP
    Health Aff (Millwood); 2006; 25(2):491-500. PubMed ID: 16522603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medicare part D and decompensation.
    Park JM; Hariprasad R; Park LT
    Psychiatr Serv; 2006 May; 57(5):722-3. PubMed ID: 16675773
    [No Abstract]   [Full Text] [Related]  

  • 7. Economic grand rounds: the economics of the new medicare drug benefit: implications for people with mental illnesses.
    Donohue JM
    Psychiatr Serv; 2005 Jun; 56(6):645-7. PubMed ID: 15939937
    [No Abstract]   [Full Text] [Related]  

  • 8. Trends in the prescription of psychotropic medications. The role of physician specialty.
    Olfson M; Klerman GL
    Med Care; 1993 Jun; 31(6):559-64. PubMed ID: 8502004
    [No Abstract]   [Full Text] [Related]  

  • 9. The 7 habits of highly effective psychopharmacologists: overview.
    Stahl SM
    J Clin Psychiatry; 2000 Apr; 61(4):242-3. PubMed ID: 10830143
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative prevalence of psychotropic medications among youths enrolled in the SCHIP and privately insured youths.
    Safer DJ; Zito JM; Gardner JF
    Psychiatr Serv; 2004 Sep; 55(9):1049-51. PubMed ID: 15345766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Commentary: confessions of a prescription writer.
    Combrinck-Graham L
    J Marital Fam Ther; 2002 Jan; 28(1):47-50. PubMed ID: 11813365
    [No Abstract]   [Full Text] [Related]  

  • 12. [Editorial: Hebebrand, J., Blanz, B., Herpertz-Dahlmann, B. & Lehmkuhl, G. 2012. Increase in the abundance of medical treatments, ethical principles and conflicts of interest in cooperation with the pharmaceutical industry].
    Frank R
    Z Kinder Jugendpsychiatr Psychother; 2013 Mar; 41(2):145-9. PubMed ID: 23425616
    [No Abstract]   [Full Text] [Related]  

  • 13. Ethical and pragmatic issues in the use of psychotropic agents in young children.
    Jensen PS
    Can J Psychiatry; 1998 Aug; 43(6):585-8. PubMed ID: 9729685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving psychiatric drug benefit management: IV. Experiences of a pharmacy advisory committee.
    Gottlieb D; Dubin WR; Ning A; Gardiner GC
    Psychiatr Serv; 2004 Nov; 55(11):1210-2. PubMed ID: 15534007
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of neuropsychiatric symptoms in dementia.
    Friedman M
    Med Health R I; 2012 Jul; 95(7):212-3. PubMed ID: 22928233
    [No Abstract]   [Full Text] [Related]  

  • 16. Use of medication in children with psychiatric disorders.
    Barton R
    Community Pract; 2007 Nov; 80(11):42, 44. PubMed ID: 18064853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Managed care: improving psychiatric drug benefit management: I. Lessons from Massachusetts.
    Sabin JE; Daniels N
    Psychiatr Serv; 2003 Jul; 54(7):949-51. PubMed ID: 12851429
    [No Abstract]   [Full Text] [Related]  

  • 18. Update on Psychotropic Drug Prescribing in the United States: 2014-2015.
    Greenblatt DJ; Harmatz JS; Shader RI
    J Clin Psychopharmacol; 2018 Feb; 38(1):1-4. PubMed ID: 29215384
    [No Abstract]   [Full Text] [Related]  

  • 19. Mental health policy and psychotropic drugs.
    Frank RG; Conti RM; Goldman HH
    Milbank Q; 2005; 83(2):271-98. PubMed ID: 15960772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reducing reductionism: reclaiming psychiatry.
    Sowers W
    Psychiatr Serv; 2005 Jun; 56(6):637. PubMed ID: 15939935
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.